Sharekhan is bullish on Bank of Baroda has recommended buy rating on the stock with a target price of Rs 165 in its research report dated September 14, 2022.
Posts tagged MC
Buy Bank of Baroda; target of Rs 165: Sharekhan (15-09-2022)
Visaka Industries: Valuation a pull with decent growth prospects (15-09-2022)
While the near-term demand environment remains ambiguous due to the ongoing macro challenges, margins are likely to recover in H2FY23 on the back of a decline in commodity prices
Visaka Industries: Valuation a top draw with decent growth prospects (15-09-2022)
While the near-term demand environment remains ambiguous due to the ongoing macro challenges, margins are likely to recover in H2FY23 on the back of a decline in commodity prices
Visaka Industries: Valuation a top draw with decent growth prospects (15-09-2022)
While the near-term demand environment remains ambiguous due to the ongoing macro challenges, margins are likely to recover in H2FY23 on the back of a decline in commodity prices
Buy Gravita India; target of Rs 445: Emkay Global Financial (14-09-2022)
Emkay Global Financial is bullish on Gravita India has recommended buy rating on the stock with a target price of Rs 445 in its research report dated September 14, 2022.
Buy Mahindra and Mahindra Financial Services; target of Rs 275: Sharekhan (14-09-2022)
Sharekhan is bullish on Mahindra and Mahindra Financial Services has recommended buy rating on the stock with a target price of Rs 275 in its research report dated September 13, 2022.
Buy Siemens; target of Rs 3660: ICICI Direct (14-09-2022)
ICICI Direct is bullish on Siemens has recommended buy rating on the stock with a target price of Rs 3660 in its research report dated September 14, 2022.
Buy Heranba Industries; target of Rs 745: Anand Rathi (13-09-2022)
Anand Rathi is bullish on Heranba Industries has recommended buy rating on the stock with a target price of Rs 745 in its research report dated September 12, 2022.
Buy Krishna Institute of Medical Sciences; target of Rs 1520: Anand Rathi (13-09-2022)
Anand Rathi is bullish on Krishna Institute of Medical Sciences has recommended buy rating on the stock with a target price of Rs 1520 in its research report dated September 12, 2022.
Buy Mahindra and Mahindra; target of Rs 1590: ICICI Direct (13-09-2022)
ICICI Direct is bullish on Mahindra and Mahindra has recommended buy rating on the stock with a target price of Rs 1590 in its research report dated September 13, 2022.